UnitedHealth confirms federal investigation into its Medicare practices
Medicare
Federal agenciesFacebookTweetLink
Follow
UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency.
The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations.
'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.'
The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees.
UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services.
The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers.
Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company.
UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 hours ago
- Boston Globe
Vice President JD Vance is on the road again to sell the Republicans' big new tax law
In West Pittston, Pennsylvania, Vance told attendees at an industrial machine shop that they should be able to keep more of their pay in their pockets, highlighting the law's new tax deductions on overtime. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Vance also discussed a new children's savings program called Trump Accounts and how the new law promotes energy extraction, while decrying Democrats for opposing the bill that keeps the current tax rates, which would have otherwise expired later this year. Advertisement The legislation cleared the GOP-controlled Congress by the narrowest of margins, with Vance breaking a tie vote in the Senate for the package that also sets aside hundreds of billions of dollars for Trump's immigration agenda while slashing Medicaid and food stamps. The vice president is also stepping up his public relations blitz on the bill as the White House tries to deflect attention away from the growing controversy over Jeffrey Epstein. Advertisement The disgraced financier killed himself, authorities say, in a New York jail cell in 2019 as he awaited trial on sex trafficking charges. Trump and his top allies stoked conspiracy theories about Epstein's death before Trump returned to the White House and are now reckoning with the consequences of a Justice Department announcement earlier this month that Epstein did indeed die by suicide and that no further documents about the case would be released. Questions about the case continued to dog Trump in Scotland, where he on Sunday announced a framework trade deal with the European Union. Asked about the timing of the trade announcement and the Epstein case and whether it was correlated, Trump responded: 'You got to be kidding with that.' 'No, had nothing to do with it,' Trump told the reporter. 'Only you would think that.' The White House sees the new law as a clear political boon, sending Vance to promote it in swing congressional districts that will determine whether Republicans retain their House majority next year. The northeastern Pennsylvania stop is in the district represented by Republican Rep. Rob Bresnahan, a first-term lawmaker who knocked off a six-time Democratic incumbent last fall. On Monday, Vance will be in the district of Democratic Rep. Emilia Sykes, who is a top target for the National Republican Congressional Committee this cycle. Polls before the bill's passage showed that it largely remained unpopular, although the public approves of some individual provisions such as increasing the child tax credit and allowing workers to deduct more of their tips on taxes.
Bloomberg
3 hours ago
- Bloomberg
Tata Sons Expects Reprieve From Forced IPO Amid Regulator Review
Tata Sons Pvt., the closely-held holding company of India's salt-to-software conglomerate, is not making any preparations for a near-term share sale as it believes the country's regulators will extend a deadline to take itself public, said people familiar with the matter. Following engagement with officials, the company's leaders expect it will receive official communication from the Reserve Bank of India granting extension for an initial share sale amid a nationwide review of rules governing entities that are not public-facing and do not require public funds, said the people, who asked not to be named discussing information that's sensitive.
Forbes
14 hours ago
- Forbes
Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage
There were two major announcements recently regarding prior approval of treatments and services for Medicare beneficiaries. In most medical insurance, many treatments won't be covered unless it is approved first by the insurer. It's been a source of controversy for some time. Original Medicare hasn't required prior authorization of treatments and services, with a few exceptions. For most care, providers and the patient agree on a treatment. After the treatment, paperwork for approval and payment is submitted to Medicare. Medicare recently announced a new model program that will test pre-approval. The voluntary model program will test pre-approval for some services and treatments, according to a recent announcement from the Center for Innovation of the Centers for Medicare and Medicaid Services. The model program is seeking medical providers to volunteer for the program from Jan. 1, 2026 through Dec. 31, 2031. The model will be restricted to New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Providers who volunteer and are accepted will agree to seek prior authorization for 17 items and services, including skin substitutes, deep brain stimulation for Parkinson's Disease, impotence treatment, and arthroscopy for knee osteoarthritis. A provider who volunteers for the program can choose not to seek prior approval for a case. There will be a post-treatment review of the case, and the provider will risk not being paid by Medicare for the treatment. CMS initiated the program and selected the services to be covered because of a series of reports showing waste, fraud or abuse in certain areas. For example, Medicare spent up to $5.8 billion in 2022 on unnecessary or inappropriate services that had no clinical benefit, according to the Medicare Payment Advisory Commission. Under the model, providers will submit the same information they currently submit for payment approval after a service is provided to a beneficiary. The difference is that under the model, the information will be submitted earlier and the provider will wait for approval before performing the services. CMS will select companies to receive and review the prior authorizations. It expects that they will use artificial intelligence and other tools in addition to medical professionals to review the submissions. The companies will be paid based on the extent to which they saved the government money by stopping unnecessary services. CMS said it will manage the program to avoid adverse impact on beneficiaries and providers. There was other news about pre-approval, this time involving Medicare Advantage plans. Pre-approval in Medicare Advantage plans has been controversial recently. There have been a number of recent reports and studies that found the authorization process was delaying treatment or causing patients to abandon treatment plans. Other reports indicated that a high percentage of treatments that initially were denied coverage eventually were approved if the patients or their providers appealed the than 50 major insurers who sponsor many types of insurance plans announced that they will voluntarily streamline prior authorization of treatments and services in all insurance markets, including Medicare Advantage plans. The insurers say they plan to have the new process in place by Jan. 1, 2027.
